Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Periostin-guided ICS Withdrawal in Non-eosinophilic Asthma
NCT03141424Phase 4Completed
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Jun 2022
- Primary completion
- Oct 2024
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in non-eosinophilic asthma (NEA) (2 arms), sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoints: Asthma Control Questionnaire at 52 weeks and Time from baseline to drop-out at 52 weeks. Started Jun 2022; status: completed.
02
Conditions
non-eosinophilic asthma (NEA)
Beyond the preview
Go deeper on NCT03141424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03141424.